Anti-VLA1 (CD49A) antibody pharmaceutical compositions
US10160808B2 · kind B2 · utility
0Cited by
44References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 14, 2013 |
| Grant date | Dec 25, 2018 |
| Priority date | — |
| Expiry date | Mar 1, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Formulations of anti-VLA-1 antibodies are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.